Merck’s cardiovascular future takes shape as sotatercept overachieves, PCSK9 inhibitor passes phase 2
https://www.fiercebiotech.com/biotech/mercks-cardiovascular-future-takes-shape-sotatercept-overachieves-and-oral-pcsk9-passes
Medical Innovation Exchange @ Copywrite 2021. All Rights Reserved.